BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?
BridgeBio Pharma Ownership Summary
BridgeBio Pharma is owned by 93.12% institutional investors, 5.43% insiders, and 1.45% retail investors. Kohlberg kravis roberts is the largest institutional shareholder, holding 16.56% of BBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.38% of its assets in BridgeBio Pharma shares.
BBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BridgeBio Pharma | 93.12% | 5.43% | 1.45% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Kohlberg kravis roberts | 31.06M | 16.56% | $786.77M |
| Viking global investors lp | 25.12M | 13.39% | $636.31M |
| Vanguard group | 14.05M | 7.49% | $356.01M |
| Blackrock | 12.45M | 6.64% | $315.31M |
| Aisling capital management lp | 6.07M | 3.23% | $153.71M |
| State street | 5.85M | 3.12% | $148.29M |
| Laurion capital management lp | 4.39M | 2.34% | $111.17M |
| Janus henderson group | 4.31M | 2.30% | $109.29M |
| Frazier life sciences management | 3.63M | 1.94% | $92.01M |
| Geode capital management | 3.29M | 1.75% | $83.36M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aisling capital management lp | 6.07M | 66.52% | $153.71M |
| Kohlberg kravis roberts | 31.06M | 23.60% | $786.77M |
| Superstring capital management lp | 219.84K | 7.02% | $5.57M |
| Prosight management, lp | 800.00K | 6.06% | $20.26M |
| Frazier life sciences management | 3.63M | 4.30% | $92.01M |
| M28 capital management lp | 121.20K | 3.98% | $3.07M |
| Octagon capital advisors lp | 690.00K | 2.75% | $17.48M |
| Cormorant asset management, lp | 1.86M | 2.72% | $47.07M |
| Ikarian capital | 6.00K | 2.65% | $15.20M |
| Viking global investors lp | 25.12M | 2.45% | $636.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 12.45M | 0.01% | 1.98M |
| Janus henderson group | 4.31M | 0.06% | 999.83K |
| Norges bank | 893.73K | 0.00% | 893.73K |
| Vanguard group | 14.05M | 0.01% | 832.62K |
| Susquehanna group, llp | 676.65K | 0.00% | 618.30K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lord, abbett | - | - | -2.80M |
| Cormorant asset management, lp | 1.86M | 2.72% | -1.34M |
| Perceptive advisors | - | - | -1.22M |
| Paradigm biocapital advisors lp | - | - | -1.09M |
| Laurion capital management lp | 4.39M | 1.32% | -787.46K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 893.73K | 0.00% | 893.73K | $22.64M |
| Twinbeech capital lp | 341.25K | 0.17% | 341.25K | $8.64M |
| Melqart asset management (uk) | 307.91K | 0.65% | 307.91K | $7.80M |
| Balyasny asset management | 207.28K | 0.01% | 207.28K | $5.25M |
| Susquehanna fundamental investments | 167.84K | 0.10% | 167.84K | $4.25M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -3.00 |
| Creekmur asset management | -3.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Bnp paribas arbitrage, snc | -33.00 |
| Continuum advisory | -34.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 284 | 1.43% | 174,683,428 | 2.52% | 93 | 1.02% | 152 | 11.76% | 72 | -15.29% |
| Mar 31, 2024 | 280 | 3.32% | 170,388,909 | 3.05% | 95 | 0.92% | 136 | -5.56% | 85 | 8.97% |
| Dec 31, 2023 | 271 | 10.16% | 165,339,966 | 3.06% | 101 | 1.05% | 144 | 19.01% | 78 | 1.30% |
| Sep 30, 2023 | 246 | 0.82% | 160,426,320 | 7.13% | 98 | 1.13% | 121 | 12.04% | 77 | 26.23% |
| Jun 30, 2023 | 244 | -1.61% | 149,742,658 | -1.65% | 93 | 0.94% | 108 | -24.48% | 61 | 3.39% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.51M | 2.38% | -23.17K |
| iShares Russell 2000 ETF | 3.62M | 1.92% | -8.13K |
| Vanguard Small Cap Index | 3.54M | 1.87% | 6.90K |
| SPDR® S&P Biotech ETF | 2.68M | 1.43% | 29.70K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.21M | 1.18% | 76.78K |
| Vanguard Small Cap Growth Index Inv | 1.94M | 1.03% | -2.89K |
| American Funds SMALLCAP World A | 1.71M | 0.91% | 400.00K |
| Fidelity Small Cap Index | 1.44M | 0.76% | -36.27K |
| Pictet-Biotech P USD | 1.41M | 0.75% | 38.08K |
| Pictet Biotech | 1.12M | 0.60% | 1.12M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 13, 2024 | KKR Genetic Disorder L.P. | - | Sell | $149.35M |
| Aug 19, 2024 | Kumar Neil | Chief Executive Officer | Sell | $394.89K |
| Aug 19, 2024 | Kumar Neil | Chief Executive Officer | Sell | $281.37K |
| Aug 19, 2024 | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | Sell | $42.67K |
| Aug 19, 2024 | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | Sell | $59.92K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 4 |
| 2024 Q2 | - | 3 |
| 2024 Q1 | - | 3 |
| 2023 Q4 | - | 9 |
| 2023 Q3 | - | 4 |
BBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools